CASIRIVIMAB and IMDEVIMAB {REGEN-COV}: 101 …Regeneron Pharmaceuticals’ monoclonal antibodies: a rescue pharmacotherapy for COVID-19…
Aya Allam, M.D., Steven Lippmann, M.D. Besides all the pandemic talk these days, we hear lots about coronavirus treatment with monoclonal antibodies. There are many of them. What is the big deal? Casirivimab and imdevimab are two monoclonal antibodies synthesized by the pharmaceutical company Regeneron, brand-named REGEN-COV. These dual proteins are a monoclonal antibodies intervention […]